» Subscribe Today!
More of what you want to know.
The Daily News
X

Forgot your password?
Skip Navigation LinksHome >
VOL. 129 | NO. 167 | Wednesday, August 27, 2014

Medtronic Buys Brain Stimulation Company for $200 Million

AP

Print | Front Page | Email this story | Comments ()

MINNEAPOLIS (AP) – Medtronic spent about $200 million in cash to buy a privately held company that develops deep brain stimulation technologies.

The acquisition of Sapiens Steering Brain Stimulation will make the medical device maker stronger in an emerging area of medicine, the modulation of brain function.

Neuromodulation involves the delivery of electrical pulses and drugs to specific sites in the nervous system. That can help patients manage chronic pain, movement disorders and spasticity. Deep brain stimulation is approved in Europe and the United States to treat advanced Parkinson's disease, among other conditions.

Sapiens, which is based in Eindhoven, The Netherlands, will serve as the global research and development center for Medtronic Inc.'s neuromodulation business.

Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Sign-Up For Our Free Email Edition
Get the news first with our daily email


 
Blog News, Training & Events
RECORD TOTALS DAY WEEK YEAR
PROPERTY SALES 128 128 17,998
MORTGAGES 155 155 20,990
FORECLOSURE NOTICES 0 0 0
BUILDING PERMITS 149 149 36,765
BANKRUPTCIES 60 60 11,985
BUSINESS LICENSES 19 19 5,696
UTILITY CONNECTIONS 49 49 12,297
MARRIAGE LICENSES 40 40 4,518

Weekly Edition

Issues | About

The Memphis News: Business, politics, and the public interest.